Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Apr;53(4):1132–1138. doi: 10.1172/JCI107651

Bone Marrow Erythropoiesis in the Anemia of Infection, Inflammation, and Malignancy

Stanley Zucker 1,2, Samuel Friedman 1,2, Rita M Lysik 1,2
PMCID: PMC333099  PMID: 4815078

Abstract

A major factor in the anemia of infection, inflammation, and malignancy is a relative failure of the bone marrow to increase erythropoiesis in response to a shortened red cell survival. The possible causes for this diminished marrow response are: (a) a reduced production of erythropoietin, or, (b) impaired bone marrow response to erythropoietin. In this report studies were performed on 6 normals, 13 patients with anemia from infection or inflammation, and 18 patients with anemia caused by advanced malignancy. Serum erythropoietin activity was measured using the posthypoxic, polycythemic mouse assay. Assessment of bone marrow response to erythropoietin was made by measuring 59Fe-heme synthesis in bone marrow suspensions cultured for 3 days with and without the addition of erythropoietin. The results showed that marrow heme synthesis was increased in erythropoietin-treated cultures as compared with saline control cultures by 66±8% (mean ±SE) in normals, 101±10% in patients with infection or inflammation, and 31±5% in malignancy. Serum erythropoietin levels were consistently diminished relative to expected levels for the degree of anemia in the infection-inflammatory group, but not in malignancy. In these patients, plasma inhibitors to the biological activity of erythropoietin were not detected in vitro. These studies suggest that another factor to consider in the anemia of malignancy is a decreased bone marrow response to erythropoietin. In the anemia of infection-inflammation, marrow response to erythropoietin is normal, but serum levels of erythropoietin are decreased relative to the degree of anemia.

Full text

PDF
1136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOWDLER A. J., PRANKERD T. A. Anaemia in the reticuloses. Br Med J. 1962 Apr 28;1(5286):1169–1175. doi: 10.1136/bmj.1.5286.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BUSH J. A., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. The anemia of infection. XX. The kinetics of iron metabolism in the anemia associated with chronic infection. J Clin Invest. 1956 Jan;35(1):89–97. doi: 10.1172/JCI103255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CHODOS R. B., EMERSON C. P., MILLER A., ROSS J. F. Studies of the anemia and iron metabolism in cancer. J Clin Invest. 1956 Nov;35(11):1248–1262. doi: 10.1172/JCI103380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CROSBY W. H., AKEROYD J. H. The limit of hemoglobin synthesis in hereditary hemolytic anemia; its relation to the excretion of bile pigment. Am J Med. 1952 Sep;13(3):273–283. doi: 10.1016/0002-9343(52)90282-9. [DOI] [PubMed] [Google Scholar]
  5. Cartwright G. E., Lee G. R. The anaemia of chronic disorders. Br J Haematol. 1971 Aug;21(2):147–152. doi: 10.1111/j.1365-2141.1971.tb03424.x. [DOI] [PubMed] [Google Scholar]
  6. Cartwright G. E. The anemia of chronic disorders. Semin Hematol. 1966 Oct;3(4):351–375. [PubMed] [Google Scholar]
  7. Dukes P. P., Hammond D., Shore N. A., Ortega J. A. Erythropoietin: a complex with different in vivo and in vitro activities. J Lab Clin Med. 1970 Sep;76(3):439–444. [PubMed] [Google Scholar]
  8. FREIREICH E. J., MILLER A., EMERSON C. P., ROSS J. F. The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood. 1957 Nov;12(11):972–983. [PubMed] [Google Scholar]
  9. FREIREICH E. J., ROSS J. F., BAYLES T. B., EMERSON C. P., FINCH S. C. Radioactive iron metabolism and erythrocyte survival studies of the mechanism of the anemia associated with rheumatoid arthritis. J Clin Invest. 1957 Jul;36(7):1043–1058. doi: 10.1172/JCI103500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Field E. O., Caughi M. N., Blackett N. M., Smithers D. W. Marrow-suppressing factors in the blood in pure red-cell aplasia, thymoma and Hodgkin's disease. Br J Haematol. 1968 Jul;15(1):101–110. doi: 10.1111/j.1365-2141.1968.tb01516.x. [DOI] [PubMed] [Google Scholar]
  11. GUTNISKY A., VAN DYKE D. Normal response to erythropoietin or hypoxia in rats made anemic with turpentine abscess. Proc Soc Exp Biol Med. 1963 Jan;112:75–78. doi: 10.3181/00379727-112-27954. [DOI] [PubMed] [Google Scholar]
  12. Goodwin J. F., Murphy B., Guillemette M. Direct measurement of serum iron and binding capacity. Clin Chem. 1966 Feb;12(2):47–57. [PubMed] [Google Scholar]
  13. Hammond D., Shore N., Movassaghi N. Production, utilization and excretion of erythropoietin. I. Chronic anemias. II. Aplastic crisis. 3. Erythropoietic effects of normal plasma. Ann N Y Acad Sci. 1968 Mar 29;149(1):516–527. doi: 10.1111/j.1749-6632.1968.tb15191.x. [DOI] [PubMed] [Google Scholar]
  14. Haurani F. I., Green D. Primary defective iron reutilization. Response to testosterone therapy. Am J Med. 1967 Jan;42(1):151–158. doi: 10.1016/0002-9343(67)90013-7. [DOI] [PubMed] [Google Scholar]
  15. Hillman R. S., Henderson P. A. Control of marrow production by the level of iron supply. J Clin Invest. 1969 Mar;48(3):454–460. doi: 10.1172/JCI106002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hrinda M. E., Goldwasser E. On the mechanism of erythropoietin-induced differentiation. VI. Induced accumulation of iron by marrow cells. Biochim Biophys Acta. 1969 Nov 19;195(1):165–175. doi: 10.1016/0005-2787(69)90613-3. [DOI] [PubMed] [Google Scholar]
  17. Ito K., Reissmann K. R. Quantitative and qualitative aspects of steady state erythropoiesis induced in protein-starved rats by long-term erythropoietin injection. Blood. 1966 Mar;27(3):343–351. [PubMed] [Google Scholar]
  18. Krantz S. B., Moore W. H., Zaentz S. D. Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. J Clin Invest. 1973 Feb;52(2):324–336. doi: 10.1172/JCI107188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Krantz S. B. Response of polycythemia vera marrow to erythropoietin in vitro. J Lab Clin Med. 1968 Jun;71(6):999–1012. [PubMed] [Google Scholar]
  20. Kurnick J. E., Ward H. P., Pickett J. C. Mechanism of the anemia of chronic disorders: correlation of heamtocrit value with albumin, vitamin B 12 , transferrin, and iron stores. Arch Intern Med. 1972 Sep;130(3):323–326. doi: 10.1001/archinte.130.3.323. [DOI] [PubMed] [Google Scholar]
  21. Lange R. D., McDonald T. P., Jordan T. Antisera to erythropoietin: partial characterization of two different antibodies. J Lab Clin Med. 1969 Jan;73(1):78–90. [PubMed] [Google Scholar]
  22. Lange R. D., Simmons M. L., McDonald T. P. Use of silicone rubber membrane enclosures for preparation of erythropoietin assay mice. Ann N Y Acad Sci. 1968 Mar 29;149(1):34–39. doi: 10.1111/j.1749-6632.1968.tb15132.x. [DOI] [PubMed] [Google Scholar]
  23. Lukens J. N. Control of erythropoiesis in rats with adjuvant-induced chronic inflammation. Blood. 1973 Jan;41(1):37–44. [PubMed] [Google Scholar]
  24. RUTSTEIN D. D., INGENITO E. F., REYNOLDS W. E. The determination of albumin in human blood plasma and serum; a method based on the interaction of albumin with an anionic dye-2(4'-hydroxybenzeneazo) benzoic acid. J Clin Invest. 1954 Feb;33(2):211–221. doi: 10.1172/JCI102887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. TEALE F. W. Cleavage of the haem-protein link by acid methylethylketone. Biochim Biophys Acta. 1959 Oct;35:543–543. doi: 10.1016/0006-3002(59)90407-x. [DOI] [PubMed] [Google Scholar]
  26. Ward H. P., Kurnick J. E., Pisarczyk M. J. Serum level of erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease. J Clin Invest. 1971 Feb;50(2):332–335. doi: 10.1172/JCI106500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zucker S., Howe D. M., Weintraub L. R. Bone marrow response to erythropoietin in polycythemia vera and chronic granulocytic leukemia. Blood. 1972 Mar;39(3):341–346. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES